|1.||Alemany, Marià: 8 articles (04/2011 - 10/2003)|
|2.||Alemany, M: 7 articles (04/2010 - 06/2000)|
|3.||Fernández-López, José Antonio: 5 articles (04/2011 - 10/2003)|
|4.||Remesar, X: 5 articles (08/2006 - 06/2000)|
|5.||Esteve, Montserrat: 4 articles (11/2011 - 08/2009)|
|6.||Cabot, Cristina: 4 articles (04/2011 - 04/2005)|
|7.||Remesar, Xavier: 4 articles (04/2011 - 10/2003)|
|8.||Fernández-López, J A: 4 articles (04/2010 - 11/2000)|
|9.||Esteve, M: 4 articles (03/2009 - 06/2000)|
|10.||Ferrer-Lorente, Raquel: 4 articles (06/2007 - 09/2004)|
|1.||Body Weight (Weight, Body)
06/01/2000 - "Treatment with oleoyl-estrone resulted in a marked decrease in body weight in both strains, compared with the unchecked growth of controls. "
01/01/2004 - "Oleoyl-estrone and pair-fed groups expressed similar variations in body composition and significant body weight losses due to reduction in food intake. "
10/18/2003 - "Oleoyl-estrone decreased the body weight (38.5 kg in 27 months, final BMI: 40.5). "
08/01/2003 - "Oleoyl-estrone induced the loss of body weight (mainly body fat) in all groups. "
06/01/2000 - "Oleoyl-estrone lowers the body weight of both ob/ob and db/db mice."
01/01/2010 - "Oleoyl-estrone increases adrenal corticosteroid synthesis gene expression in overweight male rats."
08/01/2009 - "Site-related white adipose tissue lipid-handling response to oleoyl-estrone treatment in overweight male rats."
03/01/2009 - "Overweight male rats received oral oleoyl-estrone (OE) for 10 days, and were compared with controls. "
07/01/2006 - "Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats."
04/01/2010 - "Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats."
10/18/2003 - "This means that oleoyl-estrone could have a marked potential as an anti-obesity drug."
11/01/2000 - "The results agree with the postulated role of oleoyl-estrone as a ponderostat signal and open the way for its development as anti-obesity drug."
01/01/1998 - "The decreased uptake of oleoyl-estrone in rats that were obese shows that the mechanism regulating the turnover or disposal of this signal is altered in this type of genetic obesity."
01/01/2004 - "Oleoyl-estrone metabolic effects in relation with caloric restriction in inbred Beta rats with spontaneous obesity and type 2 diabetes."
11/01/2011 - "To substantiate the relation between obesity and oxidative stress and to assess the potential beneficial properties of a grapeseed proanthocyanidin extract (GSPE), the amelioration of obesity with oleoyl-estrone (OE), and the possible combined effect of GSPE and OE on the hepatic and renal antioxidant enzyme system in obesity-induced oxidative stress. "
06/01/2007 - "Oleoyl-estrone (OE) decreases appetite, maintains energy expediture, induces lipolysis (sparing protein), and decreases cholesterolemia and insulin resistance. "
05/01/2005 - "Oral treatment with oleoyl-estrone induces the loss of body fat and improvement of insulin resistance. "
10/18/2003 - "Oleoyl-estrone also decreases insulin resistance and hyperlipidemia and has no direct estrogenic effects. "
04/01/2010 - "In spite of their shared decrease of insulin resistance, oleoyl-estrone [OE], and rosiglitazone show diverging effects on body fat mass and distribution. "
04/01/2011 - "Oleoyl-estrone (OE) is a powerful anti-obesity compound that decreases food intake, decreases insulin resistance and circulating cholesterol. "
|8.||GTP-Binding Proteins (G-Protein)